NCT07084688Not yet recruiting
Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry
Source: ClinicalTrials.gov · Last updated 24 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this clinical and exploratory Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry is to establish high quality prevalence and incidence database for Cardiovascular-Kidney-Metabolic (CKM) syndrome, its major contributors, and the extent of the respective organ damaged.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 8 Jul 2025
- Start date
- 14 Jul 2025
- Primary completion date
- 31 Jul 2040
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Chronic kidney disease
- NCT number
- NCT07084688
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 14 Jul 2025 to the primary completion date, 31 Jul 2040
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Individuals with CKM syndrome stage 4 according to the AHA
- \* Individuals with clinical cardiovascular disease including:
- History of coronary artery disease, myocardial infarction, coronary artery intervention
- History of atrial fibrillation
- History of stroke
- Symptomatic peripheral artery disease (\>stage I)
- History of symptomatic HF
- History of HF hospitalisation
Other
- Inability to sign informed consent
Who the study is looking for
- At least 18 years of age
- Individuals diagnosed with cardiovascular-kidney-metabolic (CKM) syndrome stages 0 to 3 according to the American Heart Association (AHA) or liver disease defined by any of the following:
- For stage 0: Individuals without overweight/obesity, metabolic risk factors (normoglycemia, normotension, normal lipid profile), Chronic kidney disease (CKD), or Cardiovascular disease (CVD)
- Individuals with overweight/obesity or dysfunctional adipose tissue, without other metabolic risk factors or CKD
- Individuals with metabolic risk factors (hypertriglyceridemia, arterial hypertension, metabolic syndrome, diabetes) or CKD
- Subclinical Atherosclerotic cardiovascular disease (ASCVD) or subclinical heart failure (HF) in individuals with excess/dysfunctional adiposity, other metabolic risk factors, or CKD in the clinical assessment\[2\]
- Independent of CKM syndrome stages, individual with signs of hepatic steatosis on imaging
- Willingness to provide informed consent
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical Outpatient Department of the University Hospital Basel Coordinator of this site? Confirm its status | Basel | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.